High risk gestational trophoblastic diseases: Diagnosis and primary management with EMACO chemotherapy
DOI:
https://doi.org/10.21276/apjhs.2015.2.4.18Keywords:
Gestational trophoblastic disease, chemotherapy, diagnosisAbstract
Gestational trophoblastic disease (GTD) is characterized by abnormal proliferation of pregnancy associated trophoblastic tissue with malignant potential. GTD covers a spectrum of tumors and tumor-like conditions and may occur in a benign form as hydatiform mole or as malignancy in the form of invasive mole or choriocarcinoma. Gestational trophoblastic neoplasms are now some of the most curable of all solid tumors, with cure rates >90% even in the presence of widespread metastatic disease. An analytical prospective study of 25 patients with high risk GTN who were evaluated from a period of June 2012 to Nov 2014 at our institute and diagnosis has been described in the paper
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.